Gene · 1459
Papers2,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting O-GlcNAc transferase promiscuity to dissect site-specific O-GlcNAcylation. | Glycobiology | 2023 | 37856504 | PubTator, text mining | PubMed |
| A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives. | PLoS One | 2023 | 37824496 | PubTator, text mining | PubMed |
| Identification of potential inhibitors of casein kinase 2 alpha of Plasmodium falciparum with potent in vitro activity. | Antimicrob Agents Chemother | 2023 | 37819090 | PubTator, text mining | PubMed |
| P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation. | Signal Transduct Target Ther | 2023 | 37806990 | PubTator, text mining | PubMed |
| Mitophagy for cardioprotection. | Basic Res Cardiol | 2023 | 37798455 | PubTator, text mining | PubMed |
| Indomethacin Induces Spermidine/Spermine-N1-Acetyltransferase-1 via the Nucleolin-CDK1 Axis and Synergizes with the Polyamine Oxidase Inhibitor Methoctramine in Lung Cancer Cells. | Biomolecules | 2023 | 37759783 | PubTator, text mining | PubMed |
| Regulation of phosphoglycerate kinase 1 and its critical role in cancer. | Cell Commun Signal | 2023 | 37723547 | PubTator, text mining | PubMed |
| Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions. | MedComm (2020) | 2023 | 37719443 | PubTator, text mining | PubMed |
| Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms. | Sci Rep | 2023 | 37704748 | PubTator, text mining | PubMed |
| CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma. | Cancer Res | 2023 | 37702657 | PubTator, text mining | PubMed |
| Role of YY1 in the Regulation of Anti-Apoptotic Gene Products in Drug-Resistant Cancer Cells. | Cancers (Basel) | 2023 | 37686541 | PubTator, text mining | PubMed |
| Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities. | Cells | 2023 | 37681903 | PubTator, text mining | PubMed |
| New therapeutic directions in type II diabetes and its complications: mitochondrial dynamics. | Front Endocrinol (Lausanne) | 2023 | 37670891 | PubTator, text mining | PubMed |
| Mitochondrial dynamics in health and disease: mechanisms and potential targets. | Signal Transduct Target Ther | 2023 | 37669960 | PubTator, text mining | PubMed |
| Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks. | PLoS Comput Biol | 2023 | 37669273 | PubTator, text mining | PubMed |
| Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions. | Cell Chem Biol | 2023 | 37652024 | PubTator, text mining | PubMed |
| Adiponectin receptor 1-mediated stimulation of Cav3.2 channels in trigeminal ganglion neurons induces nociceptive behaviors in mice. | J Headache Pain | 2023 | 37620777 | PubTator, text mining | PubMed |
| Daam2 phosphorylation by CK2α negatively regulates Wnt activity during white matter development and injury. | Proc Natl Acad Sci U S A | 2023 | 37607236 | PubTator, text mining | PubMed |
| Ribosomal Biogenesis and Heterogeneity in Development, Disease, and Aging. | Epigenomes | 2023 | 37606454 | PubTator, text mining | PubMed |
| Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review). | Int J Mol Med | 2023 | 37594127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1459/papers?page=8